• All sections
  • A - Human necessities
  • A61K - Preparations for medical, dental or toiletry purposes
  • A61K 47/68 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment

Patent holdings for IPC class A61K 47/68

Total number of patents in this class: 9659

10-year publication summary

210
377
567
987
1218
1193
1401
1459
1409
416
2015 2016 2017 2018 2019 2020 2021 2022 2023 2024

Principal owners for this class

Owner
All patents
This class
SeaGen Inc
554
215
Genentech, Inc.
3742
184
Daiichi Sankyo Company, Limited
1829
165
Regeneron Pharmaceuticals, Inc.
3650
165
MedImmune Limited
627
158
Hanmi Pharm. Co., Ltd.
546
136
ImmunoGen, Inc.
405
121
The Regents of the University of California
18943
94
Dyne Therapeutics, Inc.
157
92
Bristol-myers Squibb Company
5080
87
Pfizer Inc.
3322
79
Bolt Biotherapeutics, Inc.
105
76
Novartis AG
11238
75
ADC Therapeutics SA
129
62
Abbvie Inc.
1808
57
Mayo Foundation for Medical Education and Research
2981
57
Hangzhou DAC Biotech Co., Ltd
99
56
Hoffmann-La Roche Inc.
3060
54
CytomX Therapeutics, Inc.
205
54
Mersana Therapeutics, Inc.
106
52
Other owners 7620